Nafis Hasan's Metastasis is a deep dive into the economics and politics of cancer treatment. This makes for a dense and difficult read, but one that is well worth the effort
The idea of varying your lifestyle throughout your menstrual cycle to help relieve PMS or period pain seems intuitive, but the evidence reveals a nuanced picture, finds columnist Alexandra Thompson
It is harder for our bodies to absorb key nutrients from plant-based foods, so some vegans may be short on essential amino acids for healthy muscles and bones despite eating plenty of protein
A blood test can accurately determine whether someone without known risk factors for preeclampsia may be at risk of developing the potentially fatal hypertensive pregnancy condition
A recently developed medication encourages people with cocaine use disorder to reduce their intake of the stimulant – a step towards the first approved drugs to treat the problem
From dampening inflammation to boosting mental health, the many types of dietary fibre have a surprisingly large impact throughout the body. Here's how to get your fill
Dozens of trials testing GLP-1 drugs like semaglutide, the medicine in Ozempic and Wegovy, against a placebo suggest that they really could protect against dementia
Drug trials are vital to medicine, but what of those taking part? Jennie Erin Smith's moving new book about what happened in a rural community hit by early-onset Alzheimer's disease gives them a voice
Squeezing exercise into one or two days a week seems to have similar health benefits as doing the same amount of physical activity spread out throughout the week
A new smart insole system that monitors how people walk in real time could help users improve posture and provide early warnings for conditions from plantar fasciitis to Parkinson's disease.
Among adults ages 18-49 (median age of 41 years) who were born with a hole in the upper chambers of their heart known as patent foramen ovale (PFO), strokes of unknown cause were more strongly associated with nontraditional risk factors, such as migraines, liver disease or cancer, rather than more typical factors such as high blood pressure.
Researchers have successfully employed an algorithm to identify potential mutations which increase disease risk in the noncoding regions our DNA, which make up the vast majority of the human genome. The findings could serve as the basis for detecting disease-associated variants in a range of common diseases.
Scientists could reshape cancer treatment by helping powerful drugs work better in the body by exploiting a surface protein called CD36 that helps pull substances into cells. This dramatically improves the uptake of a promising class of cancer-fighting drugs called PROTACs. The new drug design deliveries up to 22 times more of he drug inside cancer cells, and tumor suppression in mice.
A clinical trial conducted in a neonatal intensive care unit has identified a new treatment protocol to improve lung growth and function among preterm infants.
How do we learn new things? Neurobiologists using cutting-edge visualization techniques have revealed how changes across our synapses and neurons unfold. The findings depict how information is processed in our brain's circuitry, offering insights for neurological disorders and brain-like AI systems.
Two women meeting for the first time can judge within minutes whether they have the potential to be friends -- guided as much by smell as any other sense, research on friendship formation finds.
A team of researchers has identified a promising new approach that may one day help to restore vision in people affected by macular degeneration and other retinal disorders.
A new study has found important clues about the roles age, sex, hormonal changes and genetics play in how certain biomarkers for dementia are expressed in the blood, according to a new study.
Although knee replacements are usually covered by health insurance, amputees face roadblocks to coverage and often must prove their prosthetics are medically necessary.
Leaders of the "Make America Healthy Again” movement cheered the ascent of Robert F. Kennedy Jr. to Health and Human Services secretary, but their wish list is far from being realized.
A stressed primary care system has led many doctors to start practices that charge membership fees in exchange for shorter waits and longer appointments. Observers say the doctor shortage needs a more systemic fix.
During his first news conference as Health and Human Services secretary, Robert F. Kennedy Jr. on April 16 ticked off things he thinks kids with autism will never do, including paying taxes, holding a job, and going on a date. Kennedy’s comments go against science and reality.
The U.S. faces a crucial shortage of medical providers, especially in rural areas. The problem has been building for a while, experts say, but the pandemic accelerated it by pushing many doctors over the edge into early retirement or other fields.
Tensions between Robert F. Kennedy Jr. and his employees at the Department of Health and Human Services are mounting, as he made a series of claims about autism this week — contradicting his agency’s findings. Plus, President Donald Trump unveiled an executive order to lower drug prices as his administration explores tariffs that could raise them. Shefali Luthra of The 19th, Jessie Hellmann of CQ Roll Call, and Anna Edney of Bloomberg News join KFF Health News’ Emmarie Huetteman to discuss these stories and more. Plus, KFF Health News’ Julie Rovner interviews two University of California-San Francisco researchers about an upcoming Supreme Court case that could have major ramifications for preventive care.
A KFF Health News analysis underscores how the terminations have spared no part of the country, politically or geographically. Of the organizations that had grants cut in the first month, about 40% are in states President Donald Trump won in November.
Emotionally overwhelmed, an Indiana woman dialed a mental health hotline. She didn’t find the help she was looking for and hung up. Ultimately, she was handcuffed and hospitalized overnight. Now, amid federal cuts, she and others fear the U.S. response to similar crises will revert to more responses like that.
